Sign in

CIK 0001347178 · Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
030491827
Phone
202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 4 Insider Changes in Ownership
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 3 Insider Initial Statement of Ownership
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 8-K Event Shareholder vote results

Page 1 of 67 · 1,337 filings